Literature DB >> 1166937

Experience with 1,360 primary parotid tumors.

J E Woods, G C Chong, O H Beahrs.   

Abstract

Experience with 1,360 primary parotid tumors seen at the Mayo Clinic during two fifteen year periods, 1940 through 1954 and 1955 through 1969, is reviewed. A comparison of histopathologic classification, type of treatment indicated, recurrence rates, and survival in the two periods reveals considerably greater understanding of all factors in the later fifteen year period. The relatively high mortality still encountered among patients with high grade malignant tumors of the parotid glands indicate the nature of the challenge still to be met. Based on the data in this study, it is our opinion that superficial or total conservative parotidectomy is best employed primarily for benign tumors and that the shift to more radical operative procedures should continue in the management of malignant tumors, especially those that are less well differentiated. For experienced surgeons, exceptions might be the small superficially located tumors or the tumors in the lower pole of the gland such as Warthin's tumors. Local excision with removal of a margin of parotid parenchyma might be justifiable in such cases.

Entities:  

Mesh:

Year:  1975        PMID: 1166937     DOI: 10.1016/0002-9610(75)90484-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  18 in total

1.  PAROTOID TUMOURS: A STUDY OF 65 CASES.

Authors:  L S Vohra; Ashok Kumar; G Rajagopal; H G Mukhopadhyay
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Oncocytic carcinoma ex pleomorphic adenoma.

Authors:  Demet Etit; Ayca Tan; Umit Bayol; Deniz Altinel; Suheyla Cumurcu; Ibrahim Cukurova
Journal:  Head Neck Pathol       Date:  2009-12-10

3.  Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy.

Authors:  Trevor M Feinstein; Stephen Y Lai; Diana Lenzner; William Gooding; Robert L Ferris; Jennifer R Grandis; Eugene N Myers; Jonas T Johnson; Dwight E Heron; Athanassios Argiris
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

4.  Application of DTI and ARFI imaging in differential diagnosis of parotid tumours.

Authors:  Jinfen Yu; Yanfei Du; Yong Lu; Weidong Zhang; Dongsheng Zhang; Guangbin Wang; Chuanting Li
Journal:  Dentomaxillofac Radiol       Date:  2016-07-22       Impact factor: 2.419

5.  [Not Available].

Authors:  J P Bossé; D Cloutier
Journal:  Can Fam Physician       Date:  1976-05       Impact factor: 3.275

6.  Facial nerve dysfunction after superficial parotidectomy with or without continuous intraoperative electromyographic neuromonitoring: a prospective randomized pilot study.

Authors:  Agnaldo J Graciano; Carlos A Fischer; Guilherme V Coelho; José H Steck; Jorge R Paschoal; Carlos T Chone
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-19       Impact factor: 2.503

7.  Multinodular neck recurrence of parotid gland pleomorphic adenoma: a case report.

Authors:  Nick Papadogeorgakis; Evagelos F Kalfarentzos; Vassilis Petsinis; Eleni Parara; Maria-Emmanouela Kopaka
Journal:  Oral Maxillofac Surg       Date:  2011-06-10

8.  Magnetic resonance image biomarkers improve differentiation of benign and malignant parotid tumors through diagnostic model analysis.

Authors:  Yuebo Liu; Jiabao Zheng; Jizhi Zhao; Lijiang Yu; Xiaoping Lu; Zhihui Zhu; Chunlan Guo; Tao Zhang
Journal:  Oral Radiol       Date:  2021-01-11       Impact factor: 1.852

9.  Parotid neoplasms: a report of 250 cases and review of the literature.

Authors:  E J Dunn; T Kent; J Hines; I Cohn
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

Review 10.  Cancer of the parotid gland: role of 7th nerve preservation.

Authors:  Jeffrey D Spiro; Ronald H Spiro
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.